BIO-TECHNE Corp — Director's Dealing 2011

Aug 1, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2011-07-28

Reporting Person: VERONNEAU MARCEL (VP Hematology Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-28	Stock Option	$76.15	A	1129	Acquired	2018-07-27	Common Stock (1129)	Direct
2011-07-28	Stock Option	$76.15	A	20000	Acquired	2018-07-27	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	34569	Direct
Common Stock	6706	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$58.4	2017-07-29	Common Stock (1281)	1281	Direct
Stock Option	$66.25	2017-04-29	Common Stock (10000)	10000	Direct
Stock Option	$62.46	2016-07-23	Common Stock (494)	494	Direct
Stock Option	$79.41	2015-07-24	Common Stock (385)	385	Direct
Stock Option	$56.83	2014-07-26	Common Stock (510)	510	Direct
Stock Option	$49.43	2013-07-27	Common Stock (567)	567	Direct
Stock Option	$51.6	2012-08-17	Common Stock (475)	475	Direct

Footnotes

F1: Vested 5,000 each 6/30/12, 6/30/13, 6/30/14, 6/30/15

F2: Vested 5,000 each 4/30/11 and 4/30/12